1. Disease is multifactorial in nature; difficult to identify one particular cause

 a. Host factors

(1) Immunity to disease/natural resistance

(2) Heredity

(3) Age, gender, race

(4) Physical or morphologic factors

b. Agent factors

(1) Biologic—microbiologic

(2) Chemical—poisons, dosage levels

(3) Physical—environmental exposure

c. Environment factors

(1) Physical—geography and climate

(2) Biologic—animal hosts and vectors

(3) Social —socioeconomic, education, nutrition

2. All factors must be present to be sufficient cause for disease

3. Interplay of these factors is ongoing: to affect the disease, attack at the weakest link

Some Terms

1. Epidemic—a disease of significantly greater prevalence than normal; more than the expected number of cases; a disease that spreads rapidly through a demographic segment of a population

2. Endemic—continuing problem involving normal disease prevalence; the expected number of cases; indigenous to a population or geographic area

3. Pandemic—occurring throughout the population of a country, people, or the world

4. Mortality—death

5. Morbidity—disease

6. Rate—a numerical ratio in which the number of actual occurrences appears as the numerator and number of possible occurrences appears as the denominator, often used in compilation of data concerning the prevalence and incidence of events; measure of time is an intrinsic part of the denominator.

Berkson's Bias is a type of selection bias that occurs in case-control studies, particularly when the cases and controls are selected from a hospital or clinical setting. It arises when the selection of cases (individuals with the disease) and controls (individuals without the disease) is influenced by the presence of other conditions or factors, leading to a distortion in the association between exposure and outcome.

Key Features of Berkson's Bias

1. Hospital-Based Selection: Berkson's Bias typically occurs in studies where both cases and controls are drawn from the same hospital or clinical setting. This can lead to a situation where the controls are not representative of the general population.

2. Association with Other Conditions: Individuals who are hospitalized may have multiple health issues or risk factors that are not present in the general population. This can create a misleading association between the exposure being studied and the disease outcome.

3. Underestimation or Overestimation of Risk: Because the controls may have different health profiles compared to the general population, the odds ratio calculated in the study may be biased. This can lead to either an overestimation or underestimation of the true association between the exposure and the disease.

Example of Berkson's Bias

Consider a study investigating the relationship between smoking and lung cancer, where both cases (lung cancer patients) and controls (patients without lung cancer) are selected from a hospital. If the controls are patients with other diseases that are also related to smoking (e.g., chronic obstructive pulmonary disease), this could lead to Berkson's Bias. The controls may have a higher prevalence of smoking than the general population, which could distort the perceived association between smoking and lung cancer.

Implications of Berkson's Bias

• Misleading Conclusions: Berkson's Bias can lead researchers to draw incorrect conclusions about the relationship between exposures and outcomes, which can affect public health recommendations and clinical practices.
• Generalizability Issues: Findings from studies affected by Berkson's Bias may not be generalizable to the broader population, limiting the applicability of the results.

Mitigating Berkson's Bias

To reduce the risk of Berkson's Bias in research, researchers can:

1. Select Controls from the General Population: Instead of selecting controls from a hospital, researchers can use population-based controls to ensure a more representative sample.

2. Use Multiple Control Groups: Employing different control groups can help identify and account for potential biases.

3. Stratify Analyses: Stratifying analyses based on relevant characteristics (e.g., age, sex, comorbidities) can help to control for confounding factors.

4. Conduct Sensitivity Analyses: Performing sensitivity analyses can help assess how robust the findings are to different assumptions about the data.

Decayed-Missing-Filled Index ( DMF ) which was introduced by Klein, Palmer and Knutson in 1938 and modified by WHO:

1. DMF teeth index (DMFT) which measures the prevalence of dental caries/Teeth.
2. DMF surfaces index (DMFS) which measures the severity of dental caries.
The components are:

D component:
Used to describe (Decayed teeth) which include:
1. Carious tooth.
2. Filled tooth with recurrent decay.
3. Only the root are left.
4. Defect filling with caries.
5. Temporary filling.
6. Filled tooth surface with other surface decayed

M component:
Used to describe (Missing teeth due to caries) other cases should be excluded these are:
1. Tooth that extracted for reasons other than caries should be excluded, which include:
 a- Orthodontic treatment.
 b- Impaction.
 c- Periodontal disease.
2. Unerupted teeth.
3. Congenitally missing.
4. Avulsion teeth due to trauma or accident.

F component:
Used to describe (Filled teeth due to caries).

Teeth were considered filled without decay when one or more permanent restorations were present and there was no secondary (recurrent) caries or other area of the tooth with primary caries.
A tooth with a crown placed because of previous decay was recorded in this category.

Teeth restored for reason other than dental caries should be excluded, which include:
1. Trauma (fracture).
2. Hypoplasia (cosmatic purposes).
3. Bridge abutment (retention).
4. Seal a root canal due to trauma.
5. Fissure sealant.
6. Preventive filling.

1. A tooth is considered to be erupted when just the cusp tip of the occlusal surface or incisor edge is exposed.
The excluded teeth in the DMF index are:
a. Supernumerary teeth.
b. The third molar according to Klein, Palmer and Knutson only.

2. Limitations - DMF index can be invalid in older adults or in children because index can overestimate caries record by cases other than dental caries.

1. DMFT: a. A tooth may have several restorations but it counted as one tooth, F. b. A tooth may have restoration on one surface and caries on the other, it should be counted as D . c. No tooth must be counted more than once, D M F or sound.

2. DMFS: Each tooth was recorded scored as 4 surfaces for anterior teeth and 5 surfaces for posterior teeth. a. Retained root was recorded as 4 D for anterior teeth, 5 D for posterior teeth. b. Missing tooth was recorded as 4 M for anterior teeth, 5 M for posterior teeth. c. Tooth with crown was recorded as 4 F for anterior teeth, 5 F for posterior teeth.

Calculation of DMFT \ DMFS:

1. For individual

DMF = D + M + F

2. For population 

Minimum score = Zero

Primary teeth index:
1. dmft / dmfs Maximum scores: dmft = 20 , dmfs = 88
2. deft / defs, which was introduced by Gruebbel in 1944: d- decayed tooth. e- decayed tooth indicated for extraction . f- filled tooth.
3. dft / dfs: In which the missing teeth are ignored, because in children it is difficult to make sure whether the missing tooth was exfoliated or extracted due to caries or due to serial extraction.

Mixed dentition:

Each child is given a separate index, one for permanent teeth and another for primary teeth. Information from the dental caries indices can be derived to show the:

1. Number of persons affected by dental caries (%).

2. Number of surfaces and teeth with past and present dental caries (DMFT / dmft - DMFS / dmfs).

3. Number of teeth that need treatment, missing due to caries, and have been treated ( DT/dt, MT/mt, FT/f t).

Plaque index (PlI)    

    0 = No plaque in the gingival area.
    1 = A thin film of plaque adhering to the free gingival margin and adjacent to the area of the tooth. The plaque is not readily visible, but is recognized by running a periodontal probe across the tooth surface.
    2 = Moderate accumulation of plaque on the gingival margin, within the gingival pocket, and/or adjacent to the tooth surface, which can be observed visually.
    3 = Abundance of soft matter within the gingival pocket and/or adjacent to the tooth surface.

Gingival index (GI)    

    0 = Healthy gingiva.
    1= Mild inflammation: characterized by a slight change in color, edema. No bleeding observed on gentle probing.
    2 = Moderate inflammation: characterized by redness, edema, and glazing. Bleeding on probing observed.
    3 = Severe inflammation: characterized by marked redness and edema. Ulceration with a tendency toward spontaneous bleeding.

Modified gingival index (MGI)    

    0 = Absence of inflammation.
    1 = Mild inflammation: characterized by a slight change in texture of any portion of, but not the entire marginal or papillary gingival unit.
    2 = Mild inflammation: criteria as above, but involving the entire marginal or papillary gingival unit.
    3 = Moderate inflammation: characterized by glazing, redness, edema, and/or hypertrophy of the marginal or papillary gingival unit.
    4 = Severe inflammation: marked redness, edema, and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, or ulceration.
    
Community periodontal index (CPI)    

    0 = Healthy gingiva.
    1 = Bleeding observed after gentle probing or by visualization.
    2 = Calculus felt during probing, but all of the black area of the probe remains visible (3.5-5.5 mm from ball tip).
    3 = Pocket 4 or 5 mm (gingival margin situated on black area of probe, approximately 3.5-5.5 mm from the probe tip).
    4 = Pocket > 6 mm (black area of probe is not visible).
    
Periodontal screening and recording (PSR)    

    0 = Healthy gingiva. Colored area of the probe remains visible, and no evidence of calculus or defective margins is detected.
    1 = Colored area of the probe remains visible and no evidence of calculus or defective margins is detected, but bleeding on probing is noted.
    2 = Colored area of the probe remains visible and calculus or defective margins is detected.
    3 = Colored area of the probe remains partly visible (probe depth between 3.5-5.5 mm).
    4 = Colored area of the probe completely disappears (probe depth > 5.5 mm).
 

Importance of Behavior Management in Geriatric Patients with Cognitive Impairment:

1. Safety and Comfort: Cognitive impairments such as dementia or Alzheimer's disease can lead to fear, confusion, and aggression, which may increase the risk of injury to the patient or the dental team. Proper behavior management techniques ensure a calm and cooperative environment, minimizing the risk of harm.

2. Effective Communication: Patients with cognitive impairments often have difficulty understanding and following instructions, which can lead to poor treatment outcomes if not managed effectively. Careful and empathetic communication is essential for successful treatment.

3. Patient Cooperation: Engaging and reassuring patients can enhance their willingness to participate in the dental care process, which is critical for accurate diagnosis and treatment planning.

4. Maintenance of Dignity and Autonomy: Patients with cognitive impairments are particularly vulnerable to losing their sense of self-worth. Sensitive behavior management strategies can help maintain their dignity and allow them to make informed decisions as much as possible.

Challenges in Treating Geriatric Patients with Cognitive Impairment:

- Memory Loss: Patients may forget why they are at the dental office, what procedures were done, or instructions given, necessitating repetition and patience.
- Language and Comprehension Difficulties: They may struggle to understand questions or instructions, making communication challenging.
- Behavioral and Psychological Symptoms of Dementia (BPSD): These include agitation, aggression, depression, and anxiety, which can complicate the delivery of care.
- Physical Limitations: Cognitive impairments often coexist with physical disabilities, which may necessitate specialized approaches for positioning, providing care, and ensuring patient comfort.
- Medication Side Effects: Drugs used to manage cognitive symptoms can cause xerostomia, increased risk of caries, and other oral health issues that require careful consideration during treatment.

Strategies for Behavior Management:

1. Pre-Appointment Preparation: Involve caregivers in the appointment planning process, obtaining medical histories, and preparing patients for what to expect during the visit.
2. Environmental Modification: Create a calm, familiar, and non-threatening environment with minimal sensory stimulation, such as using soothing music, lighting, and comfortable seating.
3. Simplified Communication: Use clear, simple language, speak slowly and loudly if necessary, and avoid medical jargon.
4. Non-verbal Communication: Employ non-verbal cues, gestures, and visual aids to support understanding.
5. Building Rapport: Establish trust by introducing oneself, maintaining eye contact, and using a gentle touch.
6. Recognizing and Addressing Pain: Patients with cognitive impairments may not be able to communicate pain effectively. Regular assessment and use of pain management techniques are critical.
7. Pharmacological Interventions: In some cases, short-term or as-needed medications may be necessary to manage anxiety or agitation, but should be used judiciously due to potential side effects.
8. Behavioral Interventions: Employ techniques such as distraction, relaxation, and desensitization to reduce anxiety.
9. Task Simplification: Break down complex procedures into smaller, more manageable steps.
10. Use of Caregivers: Caregivers can provide comfort, support, and assistance during appointments, and can help reinforce instructions post-treatment.
11. Consistency and Routine: Maintain a consistent approach and routine during appointments to reduce confusion.
12. Cognitive Stimulation: Engage patients with familiar objects or topics to help orient them during the visit.
13. Therapeutic Touch: Use therapeutic touch, such as hand-over-mouth or hand-over-hand techniques, to guide patients through procedures and build trust.
14. Positive Reinforcement: Reward cooperative behavior with verbal praise, physical comfort, or small treats if appropriate.
15. Recognizing Triggers: Identify and avoid situations that may lead to agitation or distress, such as certain sounds or procedures.
16. Education and Training: Ensure that the dental team is well-informed about cognitive impairments and best practices for behavior management.

A test of significance in dentistry, as in other fields of research, is a statistical method used to determine whether observed results are likely due to chance or if they are statistically significant, meaning that they are reliable and not random. It helps dentists and researchers make inferences about the validity of their hypotheses.

The procedure for conducting a test of significance typically involves the following steps:

1. Formulate a Null Hypothesis (H0) and an Alternative Hypothesis (H1): The null hypothesis is a statement that assumes there is no significant difference between groups or variables being studied, while the alternative hypothesis suggests that there is a significant difference. For example, in a dental study comparing two different toothpaste brands for their effectiveness in reducing plaque, the null hypothesis might be that there is no difference in plaque reduction between the two brands, while the alternative hypothesis would be that one brand is more effective than the other.

2. Choose a significance level (α): This is the probability of incorrectly rejecting the null hypothesis when it is true. Common significance levels are 0.05 (5%) or 0.01 (1%).

3. Determine the sample size: Depending on the research question, power analysis or literature review may help determine the appropriate sample size needed to detect a clinically significant difference.

4. Collect data: Gather data from a sample of patients or subjects under controlled conditions or from existing databases.

5. Calculate test statistics: This involves calculating a value that represents the magnitude of the difference between the observed data and what would be expected if the null hypothesis were true. Common test statistics include the t-test, chi-square test, and ANOVA (Analysis of Variance).

6. Determine the p-value: The p-value is the probability of obtaining the observed results or results more extreme than those observed if the null hypothesis were true. It is calculated based on the test statistic and the chosen significance level.

7. Compare the p-value to the significance level (α): If the p-value is less than the significance level, the result is considered statistically significant. If the p-value is greater than the significance level, the result is not statistically significant, and the null hypothesis is not rejected.

8. Interpret the results: Based on the p-value, make a decision about the null hypothesis. If the p-value is less than the significance level, reject the null hypothesis and accept the alternative hypothesis. If the p-value is greater than the significance level, fail to reject the null hypothesis.

Here is a simplified example of a test of significance applied to dentistry:

Suppose you are comparing two different toothpaste brands to determine if there is a significant difference in their effectiveness in reducing dental plaque. You conduct a study with 50 participants who are randomly assigned to use either brand A or brand B for a month. After a month, you measure the plaque levels of all participants.

1. Null Hypothesis (H0): There is no significant difference in plaque reduction between the two toothpaste brands.
2. Alternative Hypothesis (H1): There is a significant difference in plaque reduction between the two toothpaste brands.
3. Significance Level (α): 0.05

Now, let's say you collected the data and found that the mean plaque reduction for brand A was 25%, with a standard deviation of 5%, and for brand B, the mean was 30%, with a standard deviation of 4%. You could use an independent samples t-test to compare the two groups' means.

4. Calculate the t-statistic: t = (Mean of Brand B - Mean of Brand A) / (Standard Error of the Difference)
5. Find the p-value associated with the calculated t-statistic. If the p-value is less than 0.05, you reject the null hypothesis.

If the p-value is less than 0.05, you can conclude that there is a statistically significant difference in plaque reduction between the two toothpaste brands, supporting the alternative hypothesis that one brand is more effective than the other. This could lead to further research or a change in dental hygiene recommendations.

In dental applications, tests of significance are commonly used in studies examining the effectiveness of different treatments, materials, and procedures. For instance, they can be applied to compare the success rates of different types of dental implants, the efficacy of various tooth whitening methods, or the impact of oral hygiene interventions on periodontal health. Understanding the statistical significance of these findings allows dentists to make evidence-based decisions and recommendations for patient care.